Dr. Timothy R. Donahue is a nationally recognized surgical oncologist, pancreatic surgeon, surgeon-scientist, and academic leader with expertise in pancreatic and other gastrointestinal cancers and complex pancreatic surgery. As Chair of the Department of Surgery at Weill Cornell Medicine and Surgeon-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center, he leads a multidisciplinary department dedicated to providing exceptional surgical care while advancing scientific discovery and surgical education.

Dr. Donahue specializes in the surgical treatment of pancreatic and other gastrointestinal cancers, with particular expertise in pancreatic cancer and complex pancreatic surgery. His approach emphasizes multidisciplinary care, bringing together surgeons, medical oncologists, gastroenterologists, radiation oncologists, radiologists, pathologists, and other specialists to develop an individualized treatment plan for each patient. His clinical practice is closely integrated with research and clinical trials, providing patients access to promising new therapies and treatment approaches.

As a surgeon-scientist, Dr. Donahue’s research focuses on understanding the interaction between pancreatic cancer and the immune system and developing new strategies to overcome treatment resistance. His laboratory and translational research programs seek to move discoveries from the laboratory into clinical trials and, ultimately, improve outcomes for patients with pancreatic cancer.